PT-141 as a 'mood enhancer' and libido booster: what TikTok gets wrong

What did @anabolictemple actually say?

Here's the honest answer: the transcript and the caption are two completely different things. The spoken words are a generic motivational speech, nothing about peptides, PT-141, dosing, or libido. The actual peptide claims live entirely in the caption, which promotes PT-141 as "a mood enhancer" that "increases the sex drive" and singles out women with a specific dosage recommendation that gets cut off at "2."

That disconnect matters. The video is being indexed under peptide content with claims about a pharmacologically active compound, but the creator never actually explains the mechanism, the risks, or the regulatory status of what they're recommending. What we're fact-checking is effectively marketing copy dressed as wellness advice.

Does the science back this up?

Partially, and with significant caveats. PT-141, also known as bremelanotide, does have real clinical evidence behind it for female sexual dysfunction, but the framing here oversimplifies the pharmacology in ways that matter.

Bremelanotide is an FDA-approved drug (Vyleesi) for hypoactive sexual desire disorder in premenopausal women. It works by activating melanocortin receptors, particularly MC3R and MC4R, in the central nervous system rather than acting on the vascular system the way older sexual health drugs do. That CNS mechanism is why it gets called a "mood enhancer" in biohacking circles. However, calling it simply a mood enhancer misrepresents how it works. The clinical trials, including the pivotal Phase 3 data published by Simon et al. (2019, Obstetrics and Gynecology), showed improvements in desire and reductions in distress, not a broad mood lift you would expect from, say, a dopaminergic compound.

The "very effective for women" framing is defensible in the context of HSDD, but that is a diagnosed clinical condition. The leap to general wellness or "glowup" use has no peer-reviewed support.

What did they get wrong (or right)?

They got the basic pharmacology directionally correct: PT-141 does influence sexual desire, and the evidence is stronger in women than in men. Credit where it's due. The FDA approval is real, and the CNS mechanism distinguishing it from PDE5 inhibitors is genuinely interesting science.

What they got wrong is substantial. First, calling it a "mood enhancer" without qualification is misleading. Bremelanotide's effects are specific to sexual desire and related distress. The mood-enhancement language implies a broader antidepressant or anxiolytic effect that the evidence does not support. Second, the dosage reference for women, cut off at "2," is a problem regardless of what number follows it. Vyleesi is administered as a subcutaneous injection of 1.75 mg, and compounded versions vary widely. Publishing dosage guidance on TikTok for an injectable compound with known side effects including nausea, flushing, and transient blood pressure increases is irresponsible. Dhillo et al. (2007, Journal of Clinical Endocrinology and Metabolism) documented these hemodynamic effects in early trials. Third, there is zero mention that PT-141 is a prescription drug in the United States, not a supplement you order freely.

What should you actually know?

PT-141 is not a peptide you experiment with based on a TikTok caption. Here is what the evidence actually supports.

• Bremelanotide has FDA approval specifically for HSDD in premenopausal women, not for general libido optimization or mood improvement in healthy people.
• Common side effects in clinical trials included nausea in roughly 40% of participants, flushing, and transient increases in blood pressure, according to the prescribing information and Simon et al. (2019).
• The drug is contraindicated in people with cardiovascular disease due to those blood pressure effects.
• Compounded PT-141, the version circulating in biohacking communities, is not equivalent to FDA-approved Vyleesi and has not been evaluated for the same purity or dosing consistency standards.
• Male use of PT-141 has less robust clinical data. Early studies showed some effect on erectile response, but no approved indication exists for men as of 2024.

If you are experiencing low sexual desire and it is causing you distress, that is a conversation worth having with a licensed clinician who can evaluate whether an approved treatment is appropriate for your specific situation.

The bottom line on this video

The caption makes real-ish claims about a real drug. The spoken content is a motivational speech that has nothing to do with peptides. That combination, pharmacological claims in the caption with zero clinical context in the actual video, is exactly the kind of content that gets people into trouble. The science on PT-141 for HSDD is legitimate. The "glowup" and "mood enhancer" framing strips away every piece of context that makes that science safe to act on.